| Primary |
| Asthma |
23.6% |
| Crohn's Disease |
14.4% |
| Product Used For Unknown Indication |
9.7% |
| Chronic Obstructive Pulmonary Disease |
8.5% |
| Bronchitis |
6.1% |
| Immunosuppression |
5.7% |
| Graft Versus Host Disease |
5.2% |
| Colitis Ulcerative |
3.1% |
| Hiv Infection |
3.1% |
| Bronchopneumonia |
2.8% |
| Colitis |
2.8% |
| Emphysema |
2.4% |
| Colitis Microscopic |
1.9% |
| Hypertension |
1.9% |
| Malignant Melanoma |
1.9% |
| Autoimmune Hepatitis |
1.4% |
| Gastroenteritis Eosinophilic |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Obstructive Airways Disorder |
1.4% |
| Rhinitis |
1.4% |
|
| Drug Ineffective |
10.3% |
| Drug Interaction |
8.8% |
| Dyspnoea |
8.8% |
| Off Label Use |
5.9% |
| Tremor |
5.9% |
| Vomiting |
5.9% |
| Wheezing |
5.9% |
| Asthma |
5.1% |
| Pancreatitis Acute |
5.1% |
| Rash |
5.1% |
| Neutropenia |
4.4% |
| Wrong Technique In Drug Usage Process |
4.4% |
| Cushing's Syndrome |
3.7% |
| Pneumonia |
3.7% |
| Heart Rate Increased |
2.9% |
| Intraocular Pressure Increased |
2.9% |
| Nausea |
2.9% |
| Product Substitution Issue |
2.9% |
| Visual Field Defect |
2.9% |
| Adrenal Insufficiency |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
21.9% |
| Asthma |
20.1% |
| Crohn's Disease |
10.8% |
| Chronic Obstructive Pulmonary Disease |
8.6% |
| Drug Use For Unknown Indication |
5.5% |
| Hypertension |
5.0% |
| Rheumatoid Arthritis |
2.9% |
| Anaesthesia |
2.9% |
| Malignant Melanoma |
2.5% |
| Pain |
2.5% |
| Dyspnoea |
2.4% |
| Colitis Ulcerative |
2.2% |
| Chronic Graft Versus Host Disease |
2.2% |
| Graft Versus Host Disease |
2.2% |
| Hypercholesterolaemia |
1.5% |
| Muscle Relaxant Therapy |
1.5% |
| Duodenal Ulcer |
1.4% |
| Dermatitis |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Epilepsy |
1.2% |
|
| Dyspnoea |
11.2% |
| Wheezing |
11.2% |
| Renal Failure |
9.4% |
| Weight Increased |
8.2% |
| Drug Ineffective |
5.9% |
| Pneumonia |
5.3% |
| Vomiting |
5.3% |
| Toxic Epidermal Necrolysis |
4.7% |
| Drug Interaction |
4.1% |
| Insomnia |
4.1% |
| Tachycardia |
4.1% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Fatigue |
2.9% |
| Graft Versus Host Disease |
2.9% |
| Hypertension |
2.9% |
| Malaise |
2.9% |
| Maternal Exposure During Pregnancy |
2.9% |
| Rash |
2.9% |
| Sepsis |
2.9% |
| Visual Impairment |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.5% |
| Crohn's Disease |
17.3% |
| Drug Use For Unknown Indication |
16.0% |
| Asthma |
9.5% |
| Chronic Obstructive Pulmonary Disease |
4.9% |
| Hypertension |
4.0% |
| Prophylaxis |
3.4% |
| Rheumatoid Arthritis |
2.8% |
| Pain |
2.3% |
| Depression |
1.6% |
| Diabetes Mellitus |
1.4% |
| Colitis Ulcerative |
1.3% |
| Inflammatory Bowel Disease |
1.2% |
| Vitamin Supplementation |
1.2% |
| Osteoporosis |
1.2% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Insomnia |
1.1% |
| Nausea |
1.1% |
| Diarrhoea |
1.0% |
| Hypersensitivity |
1.0% |
|
| Crohn's Disease |
12.2% |
| Vomiting |
11.2% |
| Weight Decreased |
8.6% |
| Dyspnoea |
7.4% |
| Pneumonia |
5.3% |
| Pyrexia |
5.3% |
| Sepsis |
5.0% |
| Wheezing |
4.9% |
| Death |
4.7% |
| Injection Site Pain |
4.3% |
| Weight Increased |
4.0% |
| Nausea |
3.5% |
| Asthma |
3.3% |
| Rash |
3.3% |
| Drug Ineffective |
3.2% |
| Pain |
3.2% |
| Fatigue |
2.9% |
| Tachycardia |
2.7% |
| Thrombocytopenia |
2.7% |
| Tremor |
2.5% |
|
| Interacting |
| Hiv Infection |
13.4% |
| Product Used For Unknown Indication |
10.6% |
| Drug Use For Unknown Indication |
9.2% |
| Asthma |
7.7% |
| Bone Pain |
6.3% |
| Osteoporosis |
5.6% |
| Antifungal Prophylaxis |
4.2% |
| Colitis Ulcerative |
4.2% |
| Emphysema |
4.2% |
| Graft Versus Host Disease |
4.2% |
| Intervertebral Disc Degeneration |
3.5% |
| Respiratory Failure |
3.5% |
| Spinal Column Stenosis |
3.5% |
| Abdominal Discomfort |
2.8% |
| Arrhythmia Supraventricular |
2.8% |
| Bronchitis |
2.8% |
| Colitis |
2.8% |
| Constipation |
2.8% |
| Dyspepsia |
2.8% |
| Gastrooesophageal Reflux Disease |
2.8% |
|
| Drug Interaction |
40.5% |
| Cushing's Syndrome |
13.5% |
| Graft Versus Host Disease |
8.1% |
| Respiratory Tract Congestion |
8.1% |
| Potentiating Drug Interaction |
5.4% |
| Secondary Hypertension |
5.4% |
| Thyroiditis |
5.4% |
| White Blood Cell Count Increased |
5.4% |
| Bronchopulmonary Aspergillosis |
2.7% |
| Stomatitis |
2.7% |
| Tooth Disorder |
2.7% |
|
